Multiple System Atrophy (MSA): A Care Staff Guide

Multiple system atrophy (MSA) is a rare, progressive neurological condition that is often mistaken for Parkinson's disease in its early stages. It affects movement, balance and the body's automatic functions such as blood pressure and bladder control. The MSA Trust's guide for GPs describes it as a palliative condition: there is no cure and no treatment that slows progression, so care focuses on managing individual symptoms and quality of life. Care staff are often the people who notice change first.

What is MSA?

According to the MSA Trust, MSA involves degeneration of nerve cells in the cerebellum, brain stem and basal ganglia. There are two main types. In MSA-P, movement is dominated by slowness and rigidity, similar to Parkinson's. In MSA-C, the main problems are unsteadiness, limb incoordination, scanning speech and eye movement difficulties. Problems with the autonomic nervous system, which controls automatic functions, are present in both. Our guide to Parkinson's disease care covers a related condition that can look similar, and progressive supranuclear palsy is another.

How common is it?

The MSA Trust's GP factsheet gives a prevalence of about 5 per 100,000 people, roughly 3,000 to 4,000 people in the UK. The most common age of onset is the mid to late fifties, although it can start between the ages of 30 and 75. Mean survival from symptom onset is given as 6 to 9 years, with some people living beyond 15 years, and progression varies widely from person to person.

Symptoms care staff may see

• Low blood pressure on standing. The factsheet describes postural hypotension as a drop of at least 20 mmHg systolic on standing, causing dizziness, falls, fatigue, blurred vision, or neck and shoulder pain.
• Bladder and bowel problems. Urgency, frequency, getting up at night, difficulty emptying the bladder and recurrent infections, plus constipation that can be severe.
• Movement problems. Slowness, rigidity, poor response to Parkinson's medicines, unsteadiness and falls.
• Speech and swallowing. Slurred or quiet speech, a weak voice, and coughing or choking on fluids.
• Sleep and breathing. Snoring, sleep apnoea, vivid dreams or acting out dreams, unintentional sighs and headaches on waking.
• Mood and thinking. Depression, anxiety, emotional lability and cognitive slowing.

Red flags

The factsheet highlights features that point away from Parkinson's, such as early bladder problems, falls much earlier than expected, quiet or slurred speech, swallowing difficulty, postural hypotension and sleep disturbance. It states that stridor, a noisy or harsh sound when breathing in, needs urgent assessment. Significant deterioration over a few days, or sudden confusion or hallucinations, suggests an infection or other acute cause that needs prompt medical review. The factsheet notes that a fever may be absent.

Helping with low blood pressure on standing

The MSA Trust content suggests several practical measures: help the person rise slowly, encourage calf pumps before standing, offer small frequent meals, encourage fluids and salt as advised by the clinical team, avoid heat and dehydration, and consider raising the head of the bed during sleep. Be alert to dizziness after meals, medicines, bathing or straining. Our guide to falls prevention in care homes explains how to build these measures into the care plan.

Swallowing and chest infections

Coughing or choking is a warning sign that raises the risk of aspiration and chest infection. Report it promptly and refer to speech and language therapy. Our guide to dysphagia and choking risk explains what to look for and how to respond.

Medicines

The factsheet advises caution with medicines. It states that most antiemetics should be avoided, with domperidone an exception, and that some antidepressants are contraindicated with Parkinson's drugs. Staff should never make changes themselves and should flag any new symptom or medicine concern to the prescriber or pharmacist.

A team approach and planning ahead

The MSA Trust lists a wide multidisciplinary team, including neurology, Parkinson's nursing, speech and language therapy, physiotherapy, occupational therapy, continence services, community matron, social services, palliative care, hospice, dietetics and the MSA Trust itself. It recommends planning future care early and monitoring regularly through community services. Record the person's wishes and preferences while they can still express them, and review the plan as the condition changes.

Supporting carers

The factsheet states that care becomes a 24-hour role, that carers are at risk of burnout and that regular respite is essential. Offer relatives clear information, a named contact and signposting to the MSA Trust, and recognise how much they are managing.

Supporting staff learning

Rare conditions are easier to care for when teams understand what they are seeing. Learnsignal's CPD library offers learning options for care and healthcare staff.

Frequently asked questions

Is MSA the same as Parkinson's disease? No. MSA shares features with Parkinson's but typically brings earlier autonomic problems, falls and poor response to Parkinson's medicines, according to the MSA Trust.

Can MSA be cured? No. There is no cure and no treatment that slows progression, but individual symptoms can be managed.

What should we do if the person suddenly gets worse? Seek prompt medical review. Sudden change, confusion or noisy breathing needs urgent attention.